The results of the cell-cell communication analysis indicated that NAT10 might inhibit the pancreatic cancer immune microenvironment by affecting T cell function, which was consistent with the results of our pathological staining and further suggested that NAT10 might inhibit the infiltration of CD8 + T cells through PD-L1. The gene discussed is NAT10; the disease is familial pancreatic carcinoma.